Renovos is the only supplier of clinically relevant (ages and disease-state) bone marrow-derived stem cell populations for regenerative medicine research conducted by academia, the pharmaceutical and biotech industries and SMEs
Skeletal stem cells (SSCs), of bone marrow origin, often referred to as Mesenchymal stem cells (MSCs), have been used as research tools in hundreds of clinical trials for various regenerative and immunomodulatory approaches
Whilst this practice has existed for decades and the MSCs research field is expanding rapidly, outcomes of various in vitro and in vivo studies are not directly comparable. This could be due to variability in the stem cell sources used, purity, or even irrelevant donor selection.
Harnessing proven enrichment protocols from the Oreffo Group, Renovos solves this problem by using established markers for mesenchymal stem cells, therefore offering prospectively immune-selected, enriched human bone marrow stem cell populations for biologics and biomaterial testing. By applying clonal culture techniques, we can also provide expanding mesenchymal stem cells of the highest purity.
About Renovos stem cells:
Lower passage, greater expansion potential
Clinically relevant by disease-state and age range for testing therapeutics/ biomaterials designed for the elderly, adults or adolescents
Donors with clinical presentations of osteoporosis, osteoarthritis or avascular necrosis as a suitable model for relevant drug/biomaterial testing
Various levels of purity of the stem cell populations:
- Unselected mesenchymal
- Stem cell-enriched